Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
- 11 June 1996
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (12) , 6129-6134
- https://doi.org/10.1073/pnas.93.12.6129
Abstract
Analyses of the human PAX-5 locus and of the 5' region of the mouse Pax-5 gene revealed that transcription from two distinct promoters results in splicing of two alternative 5' exons to the common coding sequences of exons 2-10. Transcription from the upstream promoter initiates downstream of a TATA box and occurs predominantly in B-lymphocytes, whereas the TATA-less downstream promoter is active in all Pax-5-expressing tissues. The human PAX-5 gene is located on chromosome 9 in region p13, which is involved in t(9;14)(pl3;q32) translocations recurring in small lymphocytic lymphomas of the plasmacytoid subtype and in derived large-cell lymphomas. A previous molecular analysis of a t(9;14) breakpoint from a diffuse large-cell lymphoma (KIS-1) demonstrated that the immunoglobulin heavy-chain (IgH) locus on 14q32 was juxtaposed to chromosome 9p13 sequences of unknown function [Ohno, H., Furukawa, T., Fukuhara, S., Zong, S. Q., Kamesaki, H., Shows, T. B., Le Beau, M. M., McKeithan, T. W., Kawakami, T. & Honjo, T. (1990) Proc. Natl. Acad. Sci. USA 87,628-632]. Here we show that the KIS-1 translocation breakpoint is located 1807 base pairs upstream of exon 1A of PAX-5, thus bringing the potent Emu enhancer of the IgH gene into close proximity of the PAX-5 promoters. These data suggest that deregulation of PAX-5 gene transcription by the t(9;14)(pl3;q32) translocation contributes to the pathogenesis of small lymphocytic lymphomas with plasmacytoid differentiation.Keywords
This publication has 24 references indexed in Scilit:
- The role of BSAP (Pax-5) in B-cell developmentCurrent Opinion in Genetics & Development, 1995
- PAX5 expression correlates with increasing malignancy in human astrocytomas.1995
- Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis.Genes & Development, 1992
- The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.Molecular and Cellular Biology, 1992
- Chromosomal Translocations in Lymphoid Malignancies Reveal Novel Proto-OncogenesAnnual Review of Immunology, 1992
- A positive selection vector for cloning high molecular weight DNA by the bacteriophage P1 system: improved cloning efficacy.Proceedings of the National Academy of Sciences, 1992
- Structural features in eukaryotic mRNAs that modulate the initiation of translation.Journal of Biological Chemistry, 1991
- Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.Proceedings of the National Academy of Sciences, 1990
- Transcription enhancer identified near the human Cμ immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphomaNature, 1983
- A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genesCell, 1983